tetano
Editor, Senior Moderator
Am J Cardiovasc Drugs
. 2020 Aug 1.
doi: 10.1007/s40256-020-00429-7. Online ahead of print.
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Fabian Sanchis-Gomar[SUP] 1 2 [/SUP], Carl J Lavie[SUP] 3 [/SUP], Daniel P Morin[SUP] 3 [/SUP], Carme Perez-Quilis[SUP] 4 [/SUP], Jari A Laukkanen[SUP] 5 6 [/SUP], Marco V Perez[SUP] 7 [/SUP]
Affiliations
Abstract
Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present the rationale of using amiodarone in the COVID-19 scenario, as well as whether or not amiodarone administration represents a potential strategy to prevent SARS-CoV-2 infection, rather than simply used to treat patients already symptomatic and/or with severe coronavirus disease 2019 (COVID-19), based on current evidence.
. 2020 Aug 1.
doi: 10.1007/s40256-020-00429-7. Online ahead of print.
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Fabian Sanchis-Gomar[SUP] 1 2 [/SUP], Carl J Lavie[SUP] 3 [/SUP], Daniel P Morin[SUP] 3 [/SUP], Carme Perez-Quilis[SUP] 4 [/SUP], Jari A Laukkanen[SUP] 5 6 [/SUP], Marco V Perez[SUP] 7 [/SUP]
Affiliations
- PMID: 32737841
- DOI: 10.1007/s40256-020-00429-7
Abstract
Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present the rationale of using amiodarone in the COVID-19 scenario, as well as whether or not amiodarone administration represents a potential strategy to prevent SARS-CoV-2 infection, rather than simply used to treat patients already symptomatic and/or with severe coronavirus disease 2019 (COVID-19), based on current evidence.